{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T12:10:21Z","timestamp":1698495021201},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1985,1]]},"DOI":"10.1007\/bf00319766","type":"journal-article","created":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T15:30:01Z","timestamp":1098113401000},"page":"25-27","source":"Crossref","is-referenced-by-count":18,"title":["The use of heat-treated factor VIII-concentrates in von willebrand's disease"],"prefix":"10.1007","volume":"50","author":[{"given":"M.","family":"K\ufffdhler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hellstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.1976.03270250038023","volume":"236","author":"PM Blatt","year":"1976","unstructured":"Blatt PM, Brinkhous KM, Culp HR, Krauss JS, Roberts HR (1976) Antihemophilic factor concentrate therapy in von Willebrand disease. JAMA 236: 2770?2772","journal-title":"JAMA"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9343(77)90834-8","volume":"62","author":"JR Chediak","year":"1977","unstructured":"Chediak JR, Telfer MC, Green D (1977) Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion. Am J Med 62: 369?376","journal-title":"Am J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(76)90751-8","volume":"60","author":"D Green","year":"1976","unstructured":"Green D, Potter EV (1976) Failure of AHF concentrate to control bleeding in von Willebrand's disease. Am J Med 60: 357?360","journal-title":"Am J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2141.1981.tb02688.x","volume":"47","author":"L Holberg","year":"1981","unstructured":"Holberg L, Borge L, Nilsson IM (1981) Factor VIII: C and factor VIII: CAg response in patients with hemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma. Br J Haematol 47: 587?596","journal-title":"Br J Haematol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V34.2.204.204","volume":"34","author":"CH Mielke","year":"1969","unstructured":"Mielke CH, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI (1969) The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34: 204?215","journal-title":"Blood"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00320384","volume":"49","author":"C Miyashita","year":"1984","unstructured":"Miyashita C, Hellstern P, K\u00f6hler M, von Blohn G, Wenzel E (1984) In vitro characterization of commercial factor VIII concentrates. Blut 49: 53?59","journal-title":"Blut"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1977.tb01028.x","volume":"37","author":"IM Nilsson","year":"1977","unstructured":"Nilsson IM, Hedner U (1977) Characteristics of various factor VIII concentrates used in treatment of hemophilia A. Br J Haematol 37: 543?557","journal-title":"Br J Haematol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V30.3.375.375","volume":"30","author":"HA Perkins","year":"1967","unstructured":"Perkins HA (1967) Correction of the hemostatic defects in von Willebrand's disease. Blood 30: 375?380","journal-title":"Blood"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0038-1659971","volume":"4","author":"K Schimpf","year":"1984","unstructured":"Schimpf K (1984) H\u00e4mophilie und Lebererkrankung. H\u00e4mostaseologie 4: 58?62","journal-title":"H\u00e4mostaseologie"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM197407182910305","volume":"291","author":"HJ Weiss","year":"1974","unstructured":"Weiss HJ (1974) Relation of von Willebrand factor to bleeding time. N Engl J Med 291: 420","journal-title":"N Engl J Med"},{"key":"CR11","unstructured":"Zimmermann TS, Ruggeri ZM (1982) Von Willebrand's disease. In: Spaet TH (ed) Progress in Hemostasis and Thrombosis. Grune and Stratton, pp 203?236"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00319766\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:47:07Z","timestamp":1585910827000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00319766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,1]]}},"alternative-id":["BF00319766"],"URL":"https:\/\/doi.org\/10.1007\/bf00319766","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"value":"0006-5242","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,1]]}}}